sutthirat sutthisumdang Roth MKM started coverage of Genelux (NASDAQ:GNLX) with a buy rating, citing the company’s drug Olvi-Vec in the…
Read More »sutthirat sutthisumdang Roth MKM started coverage of Genelux (NASDAQ:GNLX) with a buy rating, citing the company’s drug Olvi-Vec in the…
Read More »